2nd Process Development for Cell Therapies
As cell therapy success increasingly depends on commercial viability, scalability, and patient access, process development experts are crucial in driving efficiencies from early to late-stage development.
With the industry pipeline consolidating, it is more important than ever to employ quality by design and optimize processes for highly efficacious products that can easily transition from clinical trials to the market, securing competitive commercial viability.
Participate in the 2nd Process Development for Cell Therapies Summit alongside industry leaders to learn how to successfully deploy and commercialize novel and established cell therapy products in immunology and beyond. Gain valuable pre-competitive insights from fellow experts and peers on deploying platforms for automation, global scale-out, expedited phase development, and increased affordability.
